These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38467612)

  • 41. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
    Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
    Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of apoptosis through inactivation of ROS-dependent PI3K/Akt signaling pathway by platycodin D in human bladder urothelial carcinoma cells.
    Park C; Cha HJ; Lee H; Jeong JW; Han M; Song KS; Kim GY; Chang YC; Leem SH; Hyun JW; Kim HS; Hong SH; Choi YH
    Gen Physiol Biophys; 2022 Jul; 41(4):263-274. PubMed ID: 35938960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Photothermal exposure of polydopamine-coated branched Au-Ag nanoparticles induces cell cycle arrest, apoptosis, and autophagy in human bladder cancer cells.
    Zhao X; Qi T; Kong C; Hao M; Wang Y; Li J; Liu B; Gao Y; Jiang J
    Int J Nanomedicine; 2018; 13():6413-6428. PubMed ID: 30410328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade.
    Wang C; Wang Q; Li X; Jin Z; Xu P; Xu N; Xu A; Xu Y; Zheng S; Zheng J; Liu C; Huang P
    Biochem Biophys Res Commun; 2017 Jan; 483(1):197-202. PubMed ID: 28042037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
    Zhang L; Wang CZ; Ma M; Shao GF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway.
    Lv S; Wang W; Wang H; Zhu Y; Lei C
    BMC Cancer; 2019 Mar; 19(1):204. PubMed ID: 30845932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits bladder cancer cell growth via the mitochondrial apoptosis and JNK pathways.
    Zhu Q; Sheng Y; Li W; Wang J; Ma Y; Du B; Tang Y
    Toxicol Appl Pharmacol; 2019 May; 371():41-54. PubMed ID: 30946863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
    Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
    Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
    Gao X; Liu J; Fan D; Li X; Fang Z; Yan K; Fan Y
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34935059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melatonin-Assisted Cisplatin Suppresses Urinary Bladder Cancer Cell Proliferation and Growth through Inhibiting PrP
    Yang CC; Chuang FC; Chang CL; Huang CR; Chen HH; Yip HK; Chen YT
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
    Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
    Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The requirement of the mitochondrial protein NDUFS8 for angiogenesis.
    Xiong QW; Jiang K; Shen XW; Ma ZR; Yan XM; Xia H; Cao X
    Cell Death Dis; 2024 Apr; 15(4):253. PubMed ID: 38594244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
    Cui Z; Mu C; Wu Z; Pan S; Cheng Z; Zhang ZQ; Zhao J; Xu C
    Cell Death Dis; 2022 Jun; 13(6):569. PubMed ID: 35760803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer.
    Quan Y; Lei H; Wahafu W; Liu Y; Ping H; Zhang X
    Biomed Pharmacother; 2019 Dec; 120():109490. PubMed ID: 31574376
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fraxetin inhibits proliferation and induces apoptosis of bladder cancer through the Akt pathway in vitro and in vivo.
    Weng M; Deng Z; Huang S; Lin X; Xu N; Sun X; Wu W; Lu J; Wang D
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23556. PubMed ID: 37867445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways.
    Shin DY; Kim GY; Hwang HJ; Kim WJ; Choi YH
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):74-83. PubMed ID: 24309133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers.
    Lin CH; Chang HH; Lai CR; Wang HH; Tsai WC; Tsai YL; Changchien CY; Cheng YC; Wu ST; Chen Y
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216267
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways.
    Chen YR; Wang SC; Huang SP; Su CC; Liu PL; Cheng WC; Chuu CP; Chen JK; Bao BY; Lee CH; Ke CC; Wu HE; Chang HH; Yeh HC; Li CY
    Biomed Pharmacother; 2022 Dec; 156():113929. PubMed ID: 36411619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.